Home/Zata Pharmaceuticals/David Tabatadze, PhD

DT

David Tabatadze, PhD

President & CEO

Zata Pharmaceuticals

Therapeutic Areas

Cardiovascular Infectious Disease Genetic Disorders

Zata Pharmaceuticals Pipeline

Drug	Indication	Phase
GLS409	Acute Coronary Syndrome (Heart Attack)	Pre-clinical
ZON Platform	Undisclosed (Anti-pathogen, potential genetic disorders)	Research/Pre-clinical

Leadership Team at Zata Pharmaceuticals

Ivan Yanachkov, PhD

Chief Scientific Officer

View full Zata Pharmaceuticals profile